Reference
Ding AS, et al. Sensorineural Hearing Loss After Teprotumumab Therapy for Thyroid Eye Disease: A Case Report. Otology and Neurotology 43: e148-e152, No. 2, Feb 2022. Available from: URL: https://journals.lww.com/otology-neurotology/Fulltext/2022/02000/Sensorineural_Hearing_Loss_After_Teprotumumab.8.aspx
Rights and permissions
About this article
Cite this article
Sertraline/teprotumumab. Reactions Weekly 1905, 452 (2022). https://doi.org/10.1007/s40278-022-14842-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-14842-7